Gilteritinib Fumarate 12838-1425-01
- Manufacturer
- Astellas Pharma Inc.
- Dosage Form
- Tablet
- Product Type
- Drug For Further Processing
- Marketing Start
- November 28, 2018
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Gilteritinib Fumarate | 40 mg/1 |
Selected Package
12838-1425-01Selected68000 TABLET in 1 DRUM (12838-1425-1)